Trial NCT04287179

View at ClinicalTrials.gov 
Org. Study IDs: NN9535-4650
Secondary IDs: 2019-004234-42 U1111-1242-5426

Last trial update was posted on 2022-02-03

MeSH Interventions

Semaglutide

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions


Stopping Reasons

COVID19 impact on this trial was evaluated and a delay of at least 6-9 months was expected. In parallel, the development of a new type of pen injector, which was an important part of the trial, was ceased and thus this trial was cancelled.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID